Nano-X Outlines Scale-Up With 300-System Deal, Manufacturing Overhaul, and 2026 $35 Million Target

Overview

• Nano-X, which held its Q4 2025 earnings call Monday, reaffirmed a 2026 revenue goal of $35 million with most growth expected in the second half.
• The company detailed commercial frameworks for roughly 360–400 Nanox ARC X-ray systems, led by a Howard Technology Solutions plan for 300 units over three years with 60 in the first year.
• Management said it will close its South Korea chip line and convert the site to R&D as production moves to external partners, including a Switzerland-based manufacturer, to cut overhead and secure supply.
• Fourth-quarter results showed $3.7 million in revenue, a GAAP net loss of $33.4 million driven by a $17.5 million impairment, a non-GAAP loss of $11.2 million, about $60 million in cash, and $15.5 million raised from a share sale.
• Executives said they are shifting from service-only screening to upfront equipment sales to accelerate revenue, and cautioned that installs depend on import permits, site work, and local rules.